Gossamer Bio, Inc.
GOSS
$0.16
-$0.01-3.38%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 22.87% | 3.80% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 22.87% | 3.80% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 22.87% | 3.80% | |||
| SG&A Expenses | 71.92% | 16.12% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.31% | 8.93% | |||
| Operating Income | 2.55% | -10.57% | |||
| Income Before Tax | 1.40% | 1.86% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1.22% | 2.04% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.22% | 2.04% | |||
| EBIT | 2.55% | -10.57% | |||
| EBITDA | 2.55% | -10.57% | |||
| EPS Basic | 4.41% | 1.42% | |||
| Normalized Basic EPS | 12.81% | -27.93% | |||
| EPS Diluted | 4.41% | 1.42% | |||
| Normalized Diluted EPS | 12.81% | -27.93% | |||
| Average Basic Shares Outstanding | 3.32% | -0.60% | |||
| Average Diluted Shares Outstanding | 3.32% | -0.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||